Hi @vikas_sinha - How do you see the impact of heightened competition/disruption in diagnostic sector on Krsnaa
Below snippet from the article
Tata 1mg’s disruption in the sector with a launch of B2C (Business to Consumer) segment. The company on a pilot basis in Bengaluru has launched crucial tests like Thyroid Profile, Liver Function, Lipid Profile, and Diabetes Screening at Rs 100 per test.